Results 191 to 200 of about 313,972 (268)

Secondary data analysis of Adverse Drug Reactions reported by healthcare professionals and patients: interventions to manage ADRs of ACE inhibitors and ARBs. [PDF]

Eur J Clin Pharmacol
Spronk SH, Nielen JTH, Heier L, Jessurun N, Kant A, Karapinar-Çarkit F.   +5 more
europepmc   +1 more source

Syncing Health Timing: Exploring the Interplay of Circadian Rhythms, Obesity, and Cardiovascular Diseases

Food Safety and Health, EarlyView.
Circadian rhythm disruption impairs metabolic regulation, appetite control, and vascular function, promoting obesity and cardiovascular diseases. Evidence highlights a bidirectional relationship where metabolic disorders further disturb circadian timing.
Ghizal Fatima, István Dalmadi, Anna Jánosi, Krisztina Takács, Eszter Halmy   +4 more
wiley   +1 more source

Late-Onset Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema in a General Practitioner's Practice: A Case Report. [PDF]

Reports (MDPI)
Tirāne EJ, Tirāns E.
europepmc   +1 more source

A Pharmacogenomics‐Guided Antihypertensive Strategy for Blood Pressure Reduction in Rural China: A Cluster‐Randomized Controlled Trial

Health Care Science, EarlyView.
This manuscript reports the findings from the Pharmacogenomic‐guided Antihypertensive Strategy Trial study amidst the deteriorating blood pressure control observed globally during the COVID‐19 pandemic. A pharmacogenomics‐guided strategy achieved a 98.4% blood pressure control rate at 4 weeks in rural China.
Wangjun Qin, Mengke Yu, Ying Zhu, Queran Lin, Limei Yin, Guisheng Liu, Yaping Wang, Guangqiang Lu, Xiaofei Liu, Pengmei Li, Xudong Kong, Li Zhao, Kun Tang, Jiangli Jin, Yu Xiong, Yingnan Zhao, Yan Yan, Bo Li, Azeem Majeed, Xianbo Zuo, Yue Qiu, Jiantuo Yu, Lihong Liu   +22 more
wiley   +1 more source

Factors associated with angiotensin II stimulating vs. inhibiting antihypertensive drug use in older adults. [PDF]

BMC Geriatr
Shrestha N, Cheng TD, Worley M, Lin C, Young H, Russo M, Wei YJ.   +6 more
europepmc   +1 more source

Insulin in the regulation of the renin-angiotensin system: a new perspective on the mechanism of insulin resistance and diabetic complications

Frontiers in Endocrinology
Tatyana S. Zamolodchikova, Svetlana M. Tolpygo, Alexander V. Kotov   +2 more
doaj   +1 more source

A synthetic angiotensin II/ACE2-based hormone shunt controlling experimental hypertension. [PDF]

Nat Commun
Unal G, Mansouri M, Xie YQ, Mueller C, Charpin-El Hamri G, Fussenegger M.   +5 more
europepmc   +1 more source

Associations between antihypertensive drug-related gene polymorphisms and cardiovascular outcomes in hypertensive patients: a gene-drug interaction study. [PDF]

Sci Rep
Li Z, Liu H, Chen M, Deng J, Ma Z, Huang G, Li C, Su M, Zhong H.   +8 more
europepmc   +1 more source